_id
691b0dfb3c536f8df2318a07
Ticker
ALIKO.PA
Name
Ikonisys SA
Exchange
PA
Address
62 rue de Caumartin, Paris, France, 75009
Country
France
Sector
Healthcare
Industry
Medical Devices
Currency
EUR
Website
https://ikonisys.com
Description
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of gene rearrangements commonly associated with non-small cell lung carcinoma; oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene, which is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. In addition, it offers liquid biopsy/CTC bladder cancer detection and breast cancer early diagnostics products; CYTOfast vial solution for any type of cellular analysis; CYTOfast kit urine, a three day cytological urine test solution; CYTOfast PLUS, a liquid-phase processor that prepares thin-layer cytological samples from liquid-phase specimen; and Ikonisys intelligent application, a software designed to automatically quantify, qualify, and present cells for review. Ikonisys S.A. was incorporated in 2021 and is headquartered in Paris, France.
Last Close
1.6
Volume
672
Current Price
1.68
Change
0
Last Updated
2025-12-30T12:38:06.823Z
Image
https://logo.clearbit.com/ikonisys.com
Ipo Date
-
Market Cap
24995442
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
761019
Cost Of Revenue
752740
Gross Profit
8279
Operating Expenses
894282
Operating Income
-886003
Interest Expense
141640
Pretax Income
-1020565
Net Income
-1020564
Eps
-0.07302328942670475
Dividends Per Share
-
Shares Outstanding
15819899
Income Tax Expense
-
EBITDA
-200136
Operating Margin
-116.42324304649424
Total Other Income Expense Net
-134562
Cash
-21157
Short Term Investments
-
Receivables
773056
Inventories
654032
Total Current Assets
1449329
Property Plant Equipment
451831
Total Assets
26536928
Payables
1528976
Short Term Debt
1099084
Long Term Debt
3119451
Total Liabilities
7500034
Equity
19036894
Bs_currency_symbol
EUR
Depreciation
678789
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
1.2333661993390308
ROE
-5.360979579967194
ROA
-3.845825711250375
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
4
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
3
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
761019
Quarters > 0 > income Statement > cost Of Revenue
752740
Quarters > 0 > income Statement > gross Profit
8279
Quarters > 0 > income Statement > operating Expenses
894282
Quarters > 0 > income Statement > operating Income
-886003
Quarters > 0 > income Statement > interest Expense
141640
Quarters > 0 > income Statement > pretax Income
-1020565
Quarters > 0 > income Statement > net Income
-1020564
Quarters > 0 > income Statement > eps
-0.07302328942670475
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
13975870
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-200136
Quarters > 0 > income Statement > operating Margin
-116.42324304649424
Quarters > 0 > income Statement > total Other Income Expense Net
-134562
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-21157
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
773056
Quarters > 0 > balance Sheet > inventories
654032
Quarters > 0 > balance Sheet > total Current Assets
1449329
Quarters > 0 > balance Sheet > property Plant Equipment
451831
Quarters > 0 > balance Sheet > total Assets
26536928
Quarters > 0 > balance Sheet > payables
1528976
Quarters > 0 > balance Sheet > short Term Debt
1099084
Quarters > 0 > balance Sheet > long Term Debt
3119451
Quarters > 0 > balance Sheet > total Liabilities
7500034
Quarters > 0 > balance Sheet > equity
19036894
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
678789
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.07302328942670475
Quarters > 0 > ratios > PB
1.2333661993390308
Quarters > 0 > ratios > ROE
-5.360979579967194
Quarters > 0 > ratios > ROA
-3.845825711250375
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
713572
Quarters > 1 > income Statement > cost Of Revenue
179472
Quarters > 1 > income Statement > gross Profit
534100
Quarters > 1 > income Statement > operating Expenses
2225671
Quarters > 1 > income Statement > operating Income
-1716674
Quarters > 1 > income Statement > interest Expense
119567
Quarters > 1 > income Statement > pretax Income
-1836239
Quarters > 1 > income Statement > net Income
-1839143
Quarters > 1 > income Statement > eps
-0.1640170182740348
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
11213123
Quarters > 1 > income Statement > income Tax Expense
2904
Quarters > 1 > income Statement > EBITDA
-1095463
Quarters > 1 > income Statement > operating Margin
-240.57474228248864
Quarters > 1 > income Statement > total Other Income Expense Net
-119565
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
25080
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
650976
Quarters > 1 > balance Sheet > inventories
688585
Quarters > 1 > balance Sheet > total Current Assets
1660772
Quarters > 1 > balance Sheet > property Plant Equipment
482155
Quarters > 1 > balance Sheet > total Assets
27395030
Quarters > 1 > balance Sheet > payables
1737274
Quarters > 1 > balance Sheet > short Term Debt
1022610
Quarters > 1 > balance Sheet > long Term Debt
4024614
Quarters > 1 > balance Sheet > total Liabilities
13144327
Quarters > 1 > balance Sheet > equity
14250703
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-1839143
Quarters > 1 > cash Flow > depreciation
621273
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.1640170182740348
Quarters > 1 > ratios > PB
1.3219029713832362
Quarters > 1 > ratios > ROE
-12.905629988920547
Quarters > 1 > ratios > ROA
-6.713418455829396
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
297541
Quarters > 2 > income Statement > cost Of Revenue
116267
Quarters > 2 > income Statement > gross Profit
181274
Quarters > 2 > income Statement > operating Expenses
1540451
Quarters > 2 > income Statement > operating Income
-1359177
Quarters > 2 > income Statement > interest Expense
66753
Quarters > 2 > income Statement > pretax Income
-1400827
Quarters > 2 > income Statement > net Income
-1400827
Quarters > 2 > income Statement > eps
-0.13276189071730982
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
10551424
Quarters > 2 > income Statement > income Tax Expense
-1400827
Quarters > 2 > income Statement > EBITDA
-601385
Quarters > 2 > income Statement > operating Margin
-456.80326408797447
Quarters > 2 > income Statement > total Other Income Expense Net
-41650
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
22495
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
315115
Quarters > 2 > balance Sheet > inventories
941194
Quarters > 2 > balance Sheet > total Current Assets
1581845
Quarters > 2 > balance Sheet > property Plant Equipment
308194
Quarters > 2 > balance Sheet > total Assets
27588943
Quarters > 2 > balance Sheet > payables
1510306
Quarters > 2 > balance Sheet > short Term Debt
836991
Quarters > 2 > balance Sheet > long Term Debt
2174030
Quarters > 2 > balance Sheet > total Liabilities
11754740
Quarters > 2 > balance Sheet > equity
15834203
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-1400827
Quarters > 2 > cash Flow > depreciation
732689
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.13276189071730982
Quarters > 2 > ratios > PB
1.1195001301928489
Quarters > 2 > ratios > ROE
-8.846842496587923
Quarters > 2 > ratios > ROA
-5.077494270077691
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
319648
Quarters > 3 > income Statement > cost Of Revenue
163912
Quarters > 3 > income Statement > gross Profit
155736
Quarters > 3 > income Statement > operating Expenses
1436004
Quarters > 3 > income Statement > operating Income
-1280268
Quarters > 3 > income Statement > interest Expense
18453
Quarters > 3 > income Statement > pretax Income
-1298720
Quarters > 3 > income Statement > net Income
-1298720
Quarters > 3 > income Statement > eps
-0.12426249284308052
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
10451424
Quarters > 3 > income Statement > income Tax Expense
10
Quarters > 3 > income Statement > EBITDA
-1291460
Quarters > 3 > income Statement > operating Margin
-400.5243267594354
Quarters > 3 > income Statement > total Other Income Expense Net
-18452
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
9402
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3206
Quarters > 3 > balance Sheet > inventories
473379
Quarters > 3 > balance Sheet > total Current Assets
691116
Quarters > 3 > balance Sheet > property Plant Equipment
193912
Quarters > 3 > balance Sheet > total Assets
20852590
Quarters > 3 > balance Sheet > payables
1288000
Quarters > 3 > balance Sheet > short Term Debt
699125
Quarters > 3 > balance Sheet > long Term Debt
3207501
Quarters > 3 > balance Sheet > total Liabilities
5119950
Quarters > 3 > balance Sheet > equity
15732640
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-649360
Quarters > 3 > cash Flow > depreciation
317106
Quarters > 3 > cash Flow > change In Working Capital
62828
Quarters > 3 > cash Flow > cash From Operations
-257480
Quarters > 3 > cash Flow > capital Expenditures
173709
Quarters > 3 > cash Flow > cash From Investing
-143099
Quarters > 3 > cash Flow > cash From Financing
343917
Quarters > 3 > cash Flow > net Change In Cash
-56661
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.12426249284308052
Quarters > 3 > ratios > PB
1.1160486936712466
Quarters > 3 > ratios > ROE
-8.254940048205514
Quarters > 3 > ratios > ROA
-6.228099243307426
Quarters > 3 > ratios > FCF
-431189
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.348949469416358
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1011113
Annuals > 0 > income Statement > cost Of Revenue
295739
Annuals > 0 > income Statement > gross Profit
715374
Annuals > 0 > income Statement > operating Expenses
3766122
Annuals > 0 > income Statement > operating Income
-3050748
Annuals > 0 > income Statement > interest Expense
186320
Annuals > 0 > income Statement > pretax Income
-3237130
Annuals > 0 > income Statement > net Income
-3239970
Annuals > 0 > income Statement > eps
-0.2889444804984303
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11213123
Annuals > 0 > income Statement > income Tax Expense
2904
Annuals > 0 > income Statement > EBITDA
-1696848
Annuals > 0 > income Statement > operating Margin
-301.7217660142833
Annuals > 0 > income Statement > total Other Income Expense Net
-186382
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
25080
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
650976
Annuals > 0 > balance Sheet > inventories
688585
Annuals > 0 > balance Sheet > total Current Assets
1660772
Annuals > 0 > balance Sheet > property Plant Equipment
482155
Annuals > 0 > balance Sheet > total Assets
27395030
Annuals > 0 > balance Sheet > payables
1737274
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
4024614
Annuals > 0 > balance Sheet > total Liabilities
13144327
Annuals > 0 > balance Sheet > equity
14250703
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-3239970
Annuals > 0 > cash Flow > depreciation
1296458
Annuals > 0 > cash Flow > change In Working Capital
632461
Annuals > 0 > cash Flow > cash From Operations
-1328514
Annuals > 0 > cash Flow > capital Expenditures
37854
Annuals > 0 > cash Flow > cash From Investing
-67583
Annuals > 0 > cash Flow > cash From Financing
1411776
Annuals > 0 > cash Flow > net Change In Cash
15678
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.2889444804984303
Annuals > 0 > ratios > PB
1.227481330570148
Annuals > 0 > ratios > ROE
-22.735509960455985
Annuals > 0 > ratios > ROA
-11.826853264990037
Annuals > 0 > ratios > FCF
-1366368
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.3513504425321403
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
448557
Annuals > 1 > income Statement > cost Of Revenue
192730
Annuals > 1 > income Statement > gross Profit
255827
Annuals > 1 > income Statement > operating Expenses
2449556
Annuals > 1 > income Statement > operating Income
-2193729
Annuals > 1 > income Statement > interest Expense
73918
Annuals > 1 > income Statement > pretax Income
-2267646
Annuals > 1 > income Statement > net Income
-2267646
Annuals > 1 > income Statement > eps
-0.2169700511624062
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
10451424
Annuals > 1 > income Statement > income Tax Expense
-2
Annuals > 1 > income Statement > EBITDA
-927408
Annuals > 1 > income Statement > operating Margin
-489.0635972685746
Annuals > 1 > income Statement > total Other Income Expense Net
-73917
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
9402
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
3206
Annuals > 1 > balance Sheet > inventories
473379
Annuals > 1 > balance Sheet > total Current Assets
691116
Annuals > 1 > balance Sheet > property Plant Equipment
193912
Annuals > 1 > balance Sheet > total Assets
20852590
Annuals > 1 > balance Sheet > payables
1288000
Annuals > 1 > balance Sheet > short Term Debt
699125
Annuals > 1 > balance Sheet > long Term Debt
3207501
Annuals > 1 > balance Sheet > total Liabilities
5119950
Annuals > 1 > balance Sheet > equity
15732640
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-2267646
Annuals > 1 > cash Flow > depreciation
1266322
Annuals > 1 > cash Flow > change In Working Capital
-164037
Annuals > 1 > cash Flow > cash From Operations
-914216
Annuals > 1 > cash Flow > capital Expenditures
542437
Annuals > 1 > cash Flow > cash From Investing
-545243
Annuals > 1 > cash Flow > cash From Financing
1374875
Annuals > 1 > cash Flow > net Change In Cash
-84583
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.2169700511624062
Annuals > 1 > ratios > PB
1.0363309298375862
Annuals > 1 > ratios > ROE
-14.41363941461827
Annuals > 1 > ratios > ROA
-10.874649144302937
Annuals > 1 > ratios > FCF
-1456653
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.2474200603267813
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
935218
Annuals > 2 > income Statement > cost Of Revenue
183413
Annuals > 2 > income Statement > gross Profit
751805
Annuals > 2 > income Statement > operating Expenses
3186585
Annuals > 2 > income Statement > operating Income
-2638132
Annuals > 2 > income Statement > interest Expense
13537
Annuals > 2 > income Statement > pretax Income
-2448317
Annuals > 2 > income Statement > net Income
-2448320
Annuals > 2 > income Statement > eps
-0.25821456365491224
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
9481727
Annuals > 2 > income Statement > income Tax Expense
57739
Annuals > 2 > income Statement > EBITDA
-1351648
Annuals > 2 > income Statement > operating Margin
-282.0873849733431
Annuals > 2 > income Statement > total Other Income Expense Net
189813
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
93985
Annuals > 2 > balance Sheet > short Term Investments
35763
Annuals > 2 > balance Sheet > receivables
24643
Annuals > 2 > balance Sheet > inventories
446285
Annuals > 2 > balance Sheet > total Current Assets
693076
Annuals > 2 > balance Sheet > property Plant Equipment
301084
Annuals > 2 > balance Sheet > total Assets
21715216
Annuals > 2 > balance Sheet > payables
1082170
Annuals > 2 > balance Sheet > short Term Debt
170000
Annuals > 2 > balance Sheet > long Term Debt
2208459
Annuals > 2 > balance Sheet > total Liabilities
4043742
Annuals > 2 > balance Sheet > equity
17671474
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-2448320
Annuals > 2 > cash Flow > depreciation
1025399
Annuals > 2 > cash Flow > change In Working Capital
35456
Annuals > 2 > cash Flow > cash From Operations
-1137464
Annuals > 2 > cash Flow > capital Expenditures
874735
Annuals > 2 > cash Flow > cash From Investing
-884203
Annuals > 2 > cash Flow > cash From Financing
599127
Annuals > 2 > cash Flow > net Change In Cash
-1422541
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.25821456365491224
Annuals > 2 > ratios > PB
0.8370266181530754
Annuals > 2 > ratios > ROE
-13.854645062432255
Annuals > 2 > ratios > ROA
-11.274674863929514
Annuals > 2 > ratios > FCF
-2012199
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-2.1515828395090772
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
365144
Annuals > 3 > income Statement > cost Of Revenue
70642
Annuals > 3 > income Statement > gross Profit
28456
Annuals > 3 > income Statement > operating Expenses
805878
Annuals > 3 > income Statement > operating Income
-564232
Annuals > 3 > income Statement > interest Expense
5107
Annuals > 3 > income Statement > pretax Income
-569338
Annuals > 3 > income Statement > net Income
-571269
Annuals > 3 > income Statement > eps
-0.060249467212038485
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
9481727
Annuals > 3 > income Statement > income Tax Expense
1931
Annuals > 3 > income Statement > EBITDA
-483653
Annuals > 3 > income Statement > operating Margin
-154.52314703240367
Annuals > 3 > income Statement > total Other Income Expense Net
-5106
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
1516526
Annuals > 3 > balance Sheet > short Term Investments
46758
Annuals > 3 > balance Sheet > receivables
139108
Annuals > 3 > balance Sheet > inventories
141643
Annuals > 3 > balance Sheet > total Current Assets
1876177
Annuals > 3 > balance Sheet > property Plant Equipment
-22
Annuals > 3 > balance Sheet > total Assets
22518531
Annuals > 3 > balance Sheet > payables
977496
Annuals > 3 > balance Sheet > short Term Debt
22495
Annuals > 3 > balance Sheet > long Term Debt
1203179
Annuals > 3 > balance Sheet > total Liabilities
2504955
Annuals > 3 > balance Sheet > equity
20013576
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-571269
Annuals > 3 > cash Flow > depreciation
80579
Annuals > 3 > cash Flow > change In Working Capital
-290730
Annuals > 3 > cash Flow > cash From Operations
-781420
Annuals > 3 > cash Flow > capital Expenditures
575971
Annuals > 3 > cash Flow > cash From Investing
-636557
Annuals > 3 > cash Flow > cash From Financing
2896906
Annuals > 3 > cash Flow > net Change In Cash
1478930
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.060249467212038485
Annuals > 3 > ratios > PB
0.7390730232318303
Annuals > 3 > ratios > ROE
-2.854407428237712
Annuals > 3 > ratios > ROA
-2.5368839557074128
Annuals > 3 > ratios > FCF
-1357391
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-3.7174128562977895
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.07302328942670475
Valuation > metrics > PB
1.2333661993390308
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-5.360979579967194
Profitability > metrics > ROA
-70.41630989237089
Profitability > metrics > Net Margin
-1.3410493036310527
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3939736177550813
Risk > metrics > Interest Coverage
-6.255316294831968
Risk > final Score
35
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.5514824623486526
Liquidity > metrics > Quick Ratio
0.30261752014794185
Liquidity > final Score
25
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-9
Prev Risks > 1
-33
Prev Risks > 2
-218
Prev Liquidities > 0
28
Prev Liquidities > 1
24
Prev Liquidities > 2
15
Updated At
2026-01-20T23:08:53.116Z
Earnings History > 0 > period
2024-09-30
Earnings History > 0 > report Date
2024-11-07
Earnings History > 0 > date
2024-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.13
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.13
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-09-30
Earnings History > 1 > report Date
2022-10-27
Earnings History > 1 > date
2022-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.11
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.11
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-03-31
Earnings History > 2 > report Date
2022-04-29
Earnings History > 2 > date
2022-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.05
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-09-30
Earnings History > 3 > report Date
2021-10-29
Earnings History > 3 > date
2021-09-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.08
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.08
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-06-30
Earnings History > 4 > report Date
2021-07-01
Earnings History > 4 > date
2021-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.09
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.09
Earnings History > 4 > surprise Percent
-
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFISH her2, a microscopy application for the determination of the HER2 status of tissue sections from breast tissue biopsies; oncoFISH anaplastic lymphoma kinase (ALK), a microscopy application for the FISH based detection of gene rearrangements commonly associated with non-small cell lung carcinoma; oncoFISH PTEN, a microscopy application for the FISH based detection of deletions of the PTEN gene, which is prostate tissue biopsies; circulating tumor cells for characterization of individual tumor cells and ctDNA for global tumor genotype information; Ikonisoft explorer, a FISH scanning application for analysis of cell suspension deposited on a slide that has been hybridized with desired combination of FISH probes; and IkoniWAN Gateway, a validated remote access solution for Ikoniscope digital microscopy systems. In addition, it offers liquid biopsy/CTC bladder cancer detection and breast cancer early diagnostics products; CYTOfast vial solution for any type of cellular analysis; CYTOfast kit urine, a three day cytological urine test solution; CYTOfast PLUS, a liquid-phase processor that prepares thin-layer cytological samples from liquid-phase specimen; and Ikonisys intelligent application, a software designed to automatically quantify, qualify, and present cells for review. Ikonisys S.A. was incorporated in 2021 and is headquartered in Paris, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADangote plans stock market listing to give Nigerians ownership of refinery GhanaWeb
Read more →What Africans are saying as $20bn Dangote refinery set to hit stock market - Business Insider Africa
12/17/2025
What Africans are saying as $20bn Dangote refinery set to hit stock market Business Insider Africa
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Ikonisys SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-09-30
EPS Actual
-0.13
EPS Estimate
0
EPS Difference
-0.13
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.